MedTrace Logo

Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections

NCT01964885 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2016-02-12

No results posted yet for this study

Summary

IQP-AS-105, is a food supplement derived from garlic (Allium sativum). The objective of this study is to evaluate the possibilities of clinical use of IQP-AS-105 as a preventive medicine, based on its ability to enhance the immune system responses

Conditions

  • Common Cold
  • Upper Respiratory Tract Infections

Interventions

DIETARY_SUPPLEMENT

IQP-AS-105

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • InQpharm Group

    lead INDUSTRY

Principal Investigators

  • Udo Bongartz, PhD

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-04-30
Completion
2014-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01964885 on ClinicalTrials.gov